BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15465110)

  • 1. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis.
    Xiao BG; Liu X; Link H
    Steroids; 2004 Sep; 69(10):653-9. PubMed ID: 15465110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
    Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
    Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis.
    Pettersson A; Ciumas C; Chirsky V; Link H; Huang YM; Xiao BG
    J Neuroimmunol; 2004 Nov; 156(1-2):58-65. PubMed ID: 15465596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen affects the differentiation and function of splenic monocyte-derived dendritic cells from normal rats.
    Zhang QH; Cao J; Hu YZ; Huang YH; Lü SY; Wei GZ; Zhao YF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):129-34. PubMed ID: 15191709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.
    Munn DH; Sharma MD; Lee JR; Jhaver KG; Johnson TS; Keskin DB; Marshall B; Chandler P; Antonia SJ; Burgess R; Slingluff CL; Mellor AL
    Science; 2002 Sep; 297(5588):1867-70. PubMed ID: 12228717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis.
    Sakurai K; Zou JP; Tschetter JR; Ward JM; Shearer GM
    J Neuroimmunol; 2002 Aug; 129(1-2):186-96. PubMed ID: 12161035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
    Funeshima N; Fujino M; Kitazawa Y; Hara Y; Hara Y; Hayakawa K; Okuyama T; Kimura H; Li XK
    J Gene Med; 2005 May; 7(5):565-75. PubMed ID: 15543532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase.
    Swanson KA; Zheng Y; Heidler KM; Mizobuchi T; Wilkes DS
    Am J Respir Cell Mol Biol; 2004 Mar; 30(3):311-8. PubMed ID: 12959949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of recovery from experimental allergic encephalomyelitis induced with myelin basic protein peptide 68-86 in Lewis rats: a role for dendritic cells in inducing apoptosis of CD4+ T cells.
    Xiao BG; Huang YM; Xu LY; Ishikawa M; Link H
    J Neuroimmunol; 1999 Jun; 97(1-2):25-36. PubMed ID: 10408975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis.
    Adikari SB; Lian H; Link H; Huang YM; Xiao BG
    Clin Exp Immunol; 2004 Nov; 138(2):230-6. PubMed ID: 15498031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherent dendritic cells expressing high levels of interleukin-10 and low levels of interleukin-12 induce antigen-specific tolerance to experimental autoimmune encephalomyelitis.
    Yang JS; Xu LY; Huang YM; Van Der Meide PH; Link H; Xiao BG
    Immunology; 2000 Nov; 101(3):397-403. PubMed ID: 11106944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells.
    Zhu WH; Lu CZ; Huang YM; Link H; Xiao BG
    Mult Scler; 2007 Jan; 13(1):33-40. PubMed ID: 17294609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats.
    Xiao BG; Huang YM; Yang JS; Xu LY; Link H
    Clin Exp Immunol; 2001 Aug; 125(2):300-9. PubMed ID: 11529923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
    Munn DH; Sharma MD; Baban B; Harding HP; Zhang Y; Ron D; Mellor AL
    Immunity; 2005 May; 22(5):633-42. PubMed ID: 15894280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.
    Hwang SL; Chung NP; Chan JK; Lin CL
    Cell Res; 2005 Mar; 15(3):167-75. PubMed ID: 15780178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase.
    Lanzinger M; Jürgens B; Hainz U; Dillinger B; Raberger J; Fuchs D; Heitger A
    Eur J Immunol; 2012 May; 42(5):1117-28. PubMed ID: 22539287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.
    Koorella C; Nair JR; Murray ME; Carlson LM; Watkins SK; Lee KP
    J Biol Chem; 2014 Mar; 289(11):7747-62. PubMed ID: 24415757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoleamine 2,3-dioxygenase expression and functional activity in dendritic cells exposed to cholera toxin.
    Slavica L; Nurkkala-Karlsson M; Karlson T; Ingelsten M; Nyström J; Eriksson K
    Scand J Immunol; 2012 Aug; 76(2):113-22. PubMed ID: 22519828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.
    Hwu P; Du MX; Lapointe R; Do M; Taylor MW; Young HA
    J Immunol; 2000 Apr; 164(7):3596-9. PubMed ID: 10725715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.
    Friberg M; Jennings R; Alsarraj M; Dessureault S; Cantor A; Extermann M; Mellor AL; Munn DH; Antonia SJ
    Int J Cancer; 2002 Sep; 101(2):151-5. PubMed ID: 12209992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.